Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
0(0%)
Results Posted
56%(5 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_2
3
27%
Ph phase_1
2
18%
Ph phase_3
1
9%
Ph phase_4
4
36%
Ph not_applicable
1
9%

Phase Distribution

2

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
2(18.2%)
Phase 2Efficacy & side effects
3(27.3%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
4(36.4%)
N/ANon-phased studies
1(9.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(9)
Terminated(2)

Detailed Status

Completed9
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (18.2%)
Phase 23 (27.3%)
Phase 31 (9.1%)
Phase 44 (36.4%)
N/A1 (9.1%)

Trials by Status

completed982%
terminated218%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_2

Doxercalciferol Before Surgery in Treating Localized Prostate Cancer

NCT00022412
completedphase_2

Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

NCT00052832
completedphase_4

Pilot Study Evaluating Doxercalciferol Replacement Therapy in Kidney Transplant Recipients

NCT00889629
completedphase_3

Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002

NCT02282813
completednot_applicable

Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease

NCT00285467
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT00022412Phase 2

Doxercalciferol Before Surgery in Treating Localized Prostate Cancer

Completed
NCT00052832Phase 2

Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Completed
NCT00889629Phase 4

Pilot Study Evaluating Doxercalciferol Replacement Therapy in Kidney Transplant Recipients

Completed
NCT02282813Phase 3

Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002

Completed
NCT00285467Not Applicable

Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease

Completed
NCT00528788Phase 4

How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis

Completed
NCT00646282Phase 4

Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant Patients

Terminated
NCT00792857Phase 1

Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)

Completed
NCT00601107Phase 2

A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis

Completed
NCT00749736Phase 4

The Role of Vitamin D in Immune Function in Patients With Chronic Kidney Disease (CKD) Stages 3 and 4.

Completed
NCT00511017Phase 1

Doxercalciferol in Recurrent Pediatric Solid Tumors

Terminated

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11